View all newsletters
Receive our newsletter – data, insights and analysis delivered to you

Sanofi Active Ingredient Solutions

API Supply, Custom Synthesis, API and Pharma Contract Manufacturing Solutions

Sanofi Active Ingredient Solutions is a contract development and manufacturing organisation (CDMO) specialising in active pharmaceutical ingredient (API) supply and custom synthesis.

Address
20, avenue Raymond Aron,
92160 Antony Cedex,
Ile-de-France,
France
Phone

Sanofi Active Ingredient Solutions is a contract development and manufacturing organisation (CDMO) specialising in active pharmaceutical ingredient (API) supply and custom synthesis.

The company is the new branding of Sanofi API third party business. More than 2,000 women and men are developing, manufacturing and supplying API and technological solutions for external customers and partners in 80 countries.

To do so, the company works with passion, pride and rigour, recognising that its products are the key contributor to therapeutic solutions, helping millions of people live life to its full potential, every day, all over the world.

For innovative pharmaceutical companies, from start-ups to big pharma companies, generics pure players and through its catalogue of high-quality active ingredients and its contract development and manufacturing organisation, the company delivers expertise and customised solutions that contribute to the success of your business.

Sanofi has been supporting customers in the biotech industry since 1985.
The company has 25 years of experience in the oligosaccharides field.
Sanofi has large-volume fermentation technologies for the production of nutraceuticals, vitamins and probiotics.
The company specialises in organic chemistry with specific competencies in complex and long synthesis.
Sanofi's catalogue includes 18 prostaglandins active pharmaceutical ingredients (API).
The company's Biotech API catalogue offers 14 APIs, including Vitamin B12 and its derivatives.
Sanofi's synthesis API portfolio can be used in therapies for cardiovascular disease (CV), metabolic disorders, analgesics and nonsteroidal anti-inflammatory drugs (NSAID), central nervous system disorders and anaesthetics.
The company's corticosteroids and hormones portfolio comprises 31 APIs, anti-inflammatories, analgaesics and NSAIDs.

As a global leader, Sanofi Active Ingredient Solutions has been supporting customers for decades with innovative, efficient and safe solutions, high-quality products and premium customer service.

Contract development and manufacturing services for medical drugs

Sanofi Active Ingredient Solutions offers pharmaceutical drug developers in more than 80 countries with API and technological solutions, supporting partners from process development to regulatory submission.

Its expertise covers multiple therapeutic areas for human and animal health, including corticosteroids, hormones, viral vectors, multi-step chemistry, opiates, prostaglandins and high-active products, as well as plasmids, oligosaccharides, peptides, oligosaccharides, biotechnologies and monoclonal antibodies (mAb).

Sanofi Active Ingredient Solutions partners with innovative companies ranging from start-ups to some of the biggest pharmaceutical players. Its catalogue of high-quality APIs and customised CDMO services delivers expertise and contributes to key therapeutic solutions that help millions of people.

The company has been supporting customers for decades with innovative, efficient and safe solutions, as well as high-quality products and customer service. It focuses on the continuous improvement of manufacturing processes to optimise output and meet client expectations.

Sanofi Active Ingredient Solutions’ synthesis API portfolio covers cardiovascular disease, metabolic disorders, analgesics and non-fluorinated glucocorticoids and derivatives (NSAID), as well as central nervous system (CNS) disorders and anaesthetics.

In the corticosteroids and hormones field, the company has more than 60 years of experience, and is a fully integrated corticoids manufacturer.

Clinical supply and commercial manufacturing for the biotech industry

Sanofi Active Ingredient Solutions has been providing biotech customers with services ranging from clinical supply to commercial manufacturing since 1985. Using its dedicated biotech platform, the company has gained a significant track record, working on an average of more than 70 batches per year.

The company has 25 years of experience in the field of oligosaccharides. Sanofi Active Ingredient Solutions’ analytical expertise guarantees purity and quality, while its robust supply chain is widely recognised.

Fermentation technologies, nutraceuticals, vitamins and probiotics

Sanofi Active Ingredient Solutions offers large-volume fermentation services and has proven expertise in nutraceuticals, vitamins and probiotics.

The company meets clients’ specific demands with the highest standards.

It has a long-standing expertise in organic chemistry with specific competencies in complex and long synthesis, as well as supports its customers’ projects from early phases through to validation campaigns.

APIs for human and animal health

Sanofi Active Ingredient Solutions is a world leader in the manufacturing of prostaglandins, with a strong historical background in process development and the scale-up of new chemical entities. Its portfolio includes 18 prostaglandin APIs.

The company’s production lines are multi-purpose, allowing quick and flexible developments and scale-ups, along with constant high quality. It also provides exhaustive regulatory support to its customers.

Sanofi Active Ingredient Solutions is the sole European vitamin B12 manufacturer, while its biotech API catalogue offers 14 APIs, including antibiotics and anti-tuberculosis.

Beyond the APIs, the company has developed a strong customer-oriented policy with a large range of possible specifications and customisations.

Opiates from poppy seeds to APIs

Sanofi Active Ingredient Solutions provides opiates in forms ranging from poppy seeds to APIs.

The company’s portfolio comprises 15 opiate APIs with applications in agronomic research, industrial and agricultural production, and distribution. It grows and harvests 10,000 ha of poppies each year.

Prostaglandins

Sanofi Active Ingredient Solutions is one of the world leaders in prostaglandin, with a strong historical background in process development and the scale-up of chemical entities.

Biotech and Fermentation

We are the sole European Vitamin B12 manufacturer and our expertise in fermentation includes large capacity production.

Synthesis

We have manufactured a wide offer for multiple therapeutic areas for human and animal health.

Corticosteroids and Hormones

In the Corticosteroids & Hormones field, we have over 60 years of expertise and are one of the sole European fully integrated corticoids manufacturers.

Sanofi Manufacturing System

Sanofi's production network is a living reflection of our diversified portfolio, different technologies, various scales of operations, a vast geographical reach and different therapeutic ideas.

SANOFI Active Ingredient Solutions

Sanofi Active Ingredient Solutions have more than 2,000 people developing, manufacturing and supplying active pharmaceutical ingredients and technological solutions to external customers and partners in 80 countries.

Sanofi Manufacturing Plant, Goa, India

French pharmaceutical company Sanofi’s manufacturing facility in Goa, India, is located in the Verna Industrial Park, owned by Sanofi’s Indian arm Sanofi India, previously known as Aventis Pharma.

Ash Stevens Riverview Facility

Michigan-based contract pharmaceutical manufacturing company Ash Stevens operates two facilities for API process development and production.

Sanofi Pasteur R&D Centre

Sanofi Pasteur, the vaccine division of Sanofi, opened a new vaccine research and development centre in Toronto, Ontar

Sanofi to Create Industry-Leading European Company to Provide APIs

Sanofi plans to create a major leading European company dedicated to the production and marketing to third parties of active pharmaceutical ingredients (API), which are the essential molecules responsible for the beneficial effects used in the composition of any drug.

27 February 2020

Events Sanofi CEPiA 2017

Sanofi CEPiA has announced a number of upcoming events where the company will be showcasing its products and services.

15 May 2017

Sanofi Active Ingredient Solutions

20, avenue Raymond Aron
92160 Antony Cedex
Ile-de-France
France

CEPiA US and Canada

55 Corporate Drive
08807 Bridgewater
New Jersey
United States of America

CEPiA Japan

20-2, Nishishinjuku 3-chome
Shinjuku
163-1488 Tokyo
Japan

CEPiA Eastern Europe and Turkey

Nitrianska 100
920 27 Hlohovec
Slovakia

CEPiA India

Aventis House
54/A, Sir Mathuradas Vasanji
400 093 Mumbai
Maharashtra
India

CEPiA China

Floor 30, Phase II, Plaza 66, No.1366 Nanjing
200040 Shanghai
China

CEPiA Eastern Europe and Turkey

130 U Kabelovny
PRAGUE 10
102 37
Prague
Czech Republic

CEPiA China

Kerry Center Tower 3
20F, 1228 Yan’An Road
Jing An District
200040
Shanghai
China

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. A weekly roundup of the latest news and analysis, sent every Friday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU